Have a personal or library account? Click to login
Predictors of Left Ventricular Remodeling after Revascularized Acute Myocardial Infarction Cover

Predictors of Left Ventricular Remodeling after Revascularized Acute Myocardial Infarction

Journal of Interdisciplinary Medicine
Volume 1 (2016): Issue 1 (June 2016)
By: Sorin Pop,  Roxana Hodaş,  Edvin Benedek,  Diana Opincariu,  Nora Rat,  Laura Jani,  Alexandra Stanescu,  Monica Chitu,  Imre Benedek and  Theodora Benedek  
Open Access
|Jul 2016

References

  1. 1. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global Cardiac Remodeling After Acute Myocardial Infarction: A Study in the Rat Model. J Am Coll Cardiol. 1985;5(6):1355-1362.10.1016/S0735-1097(85)80348-X
    Search in Google Scholar
  2. 2. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.008
    Search in Google Scholar
  3. 3. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978;41(7):1127-1132.10.1016/0002-9149(78)90869-X
    Search in Google Scholar
  4. 4. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30(2):73-110.10.1016/0033-0620(87)90004-1
    Search in Google Scholar
  5. 5. Sutton MG, Sharpe N. Left Ventricular Remodeling After Myocardial Infarction — Pathophysiology and Therapy. Circulation. 2000;101(25):2981-2988.10.1161/01.CIR.101.25.2981
    Search in Google Scholar
  6. 6. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of Initial Infarct Size to Extent of Left Ventricular Remodeling in the Year After Acute Myocardial Infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-O
    Search in Google Scholar
  7. 7. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979;300(2):57-62.10.1056/NEJM197901113000202
    Search in Google Scholar
  8. 8. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol. 1982;49(5):1120-1126.10.1016/0002-9149(82)90035-2
    Search in Google Scholar
  9. 9. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74(4):693-702.10.1161/01.CIR.74.4.6933757183
    Search in Google Scholar
  10. 10. Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarct expansion. Circulation. 1991;84(5):2123-2134.10.1161/01.CIR.84.5.21231934383
    Search in Google Scholar
  11. 11. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995;25(3):567-573.10.1016/0735-1097(94)00431-O
    Search in Google Scholar
  12. 12. van Gilst WH, Kingma JH, Peels KH, Dambrink JH, St John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 1996;28(1):114-121.10.1016/0735-1097(96)00113-1
    Search in Google Scholar
  13. 13. Dujardin KS, Enriquez-Sarano M, Rossi A, Bailey KR, Seward JB. Echocardiographic Assessment of Left Ventricular Remodeling: Are Left Ventricular Diameters Suitable Tools? J Am Coll Cardiol. 1997;30(6):1534-1541.10.1016/S0735-1097(97)00329-X
    Search in Google Scholar
  14. 14. Gottdiener JS, Livengood SV, Meyer PA, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25(2):424-430.10.1016/0735-1097(94)00375-Z
    Search in Google Scholar
  15. 15. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.10.1016/j.jcmg.2010.10.00821232712
    Search in Google Scholar
  16. 16. Marwick T. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. 2003;89(Suppl3):iii2–iii8.10.1136/heart.89.suppl_3.iii2187630014594869
    Search in Google Scholar
  17. 17. Mosca L, Barrett-Connor E, Kass Wenger N. Sex/Gender Differences in Cardiovascular Disease Prevention, What a Difference a Decade Makes. Circulation. 2011;124(19):2145–2154.10.1161/CIRCULATIONAHA.110.968792336205022064958
    Search in Google Scholar
  18. 18. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-Related Differences in Myocardial Remodeling. J Am Coll Cardiol. 2010;55(11):1057-1065.10.1016/j.jacc.2009.09.06520223363
    Search in Google Scholar
  19. 19. Ednei LA, Andrey JS, dos Santos AA, et al. Are there gender differences in left ventricular remodeling after myocardial infarction in rats? Rev Bras Cir Cardiovasc. 2015;30(1):70–76.
    Search in Google Scholar
  20. 20. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91(3):173-183.10.1159/00000690610516411
    Search in Google Scholar
  21. 21. Konstam MA, Udelson JE, Anand IS, Cohn JN. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail. 2003;9(5):350-353.10.1054/j.cardfail.2003.09.00114583894
    Search in Google Scholar
  22. 22. Zornoff LAM, Matsubara BB, Matsubara LS, et al. Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction. Arq Bras Cardiol. 2006;86(4):276-282
    Search in Google Scholar
  23. 23. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225-236.10.1097/00000441-200104000-0000311307864
    Search in Google Scholar
  24. 24. Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982;66(1):55-60.10.1161/01.CIR.66.1.557083520
    Search in Google Scholar
  25. 25. Messerli FH. Cardiomyopathy of obesity: a not-so-Victorian disease. N Engl J Med. 1986;314:378-38010.1056/NEJM1986020631406082935738
    Search in Google Scholar
  26. 26. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006;98(1):116-2010.1016/j.amjcard.2006.01.06316784933
    Search in Google Scholar
  27. 27. Litwin SE. Cardiac Remodeling in Obesity Time for a New Paradigm. JACC Cardiovasc Imaging. 2010;3(3):275-7.10.1016/j.jcmg.2009.12.00420223424
    Search in Google Scholar
  28. 28. Avelar E, Cloward TV, Walker JM. Left Ventricular Hypertrophy in Severe Obesity Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass. Hypertension. 2007;49(1):34-9.10.1161/01.HYP.0000251711.92482.1417130310
    Search in Google Scholar
  29. 29. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.10.1093/eurheartj/ehm18417556348
    Search in Google Scholar
  30. 30. Park D-W, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-2027.10.1001/jama.2014.1509525399277
    Search in Google Scholar
  31. 31. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57(1):84-95.10.1161/01.RES.57.1.843891127
    Search in Google Scholar
  32. 32. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319(2):80-86.10.1056/NEJM1988071431902042967917
    Search in Google Scholar
  33. 33. Sweet CS, Emmert SE, Stabilito II, Ribeiro LG. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987;10(6):636-642.10.1097/00005344-198712000-00005
    Search in Google Scholar
  34. 34. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial cfft’cts of loneterm therapy with captopril. Circulation. 1985;72(2):406-412.10.1161/01.CIR.72.2.406
    Search in Google Scholar
  35. 35. Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol. 1992;19(3):713-721.10.1016/S0735-1097(10)80298-0
    Search in Google Scholar
  36. 36. Pfeffer MA1, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.10.1161/01.CIR.81.4.1161
    Search in Google Scholar
  37. 37. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a topographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 1989;13(7):1506-1513.10.1016/0735-1097(89)90340-9
    Search in Google Scholar
  38. 38. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994;343(8906):1115-1122.
    Search in Google Scholar
  39. 39. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345(8951):669-685.10.1016/S0140-6736(95)90865-X
    Search in Google Scholar
DOI: https://doi.org/10.1515/jim-2016-0013 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Journal RSS Feed
Language: English
Page range: 62 - 70
Submitted on: Apr 11, 2016
|
Accepted on: May 12, 2016
|
Published on: Jul 6, 2016
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
predictors,
left ventricular remodeling,
acute myocardial infarction,
echocardiography,
pPCI
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Emergency medicine and intensive-care medicine

© 2016 Sorin Pop, Roxana Hodaş, Edvin Benedek, Diana Opincariu, Nora Rat, Laura Jani, Alexandra Stanescu, Monica Chitu, Imre Benedek, Theodora Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 1 (2016): Issue 1 (June 2016)Next article